Second primary melanomas treated with BRAF blockers: Study by reflectance confocal microscopy

British Journal of Dermatology

Volumn 168, Issue 6, 2013, Pages 1230-1235

  Debarbieux, S ^a   Dalle, S ^a,b   Depaepe, L ^a   Poulalhon, N ^a,b   Balme, B ^a   Thomas, L ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VEMURAFENIB;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CASE REPORT; CONFOCAL MICROSCOPE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPILUMINESCENCE MICROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MELANOMA; PRIORITY JOURNAL; REFLECTANCE CONFOCAL MICROSCOPY; SECOND CANCER;

ANTINEOPLASTIC AGENTS; DERMOSCOPY; HUMANS; INDOLES; MELANOMA; MICROSCOPY, CONFOCAL; NEOPLASMS, SECOND PRIMARY; PROTO-ONCOGENE PROTEINS B-RAF; SKIN NEOPLASMS; SULFONAMIDES;

EID: 84878662326     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12210     Document Type: Article

References (16)

1. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507-16.
2. Dalle S, Poulalhon N, Thomas L,. Vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 365: 1448-9.
3. Zimmer L, Hillen U, Livingstone E, et al. Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition. J Clin Oncol 2012; 30: 2375-83.
4. Dalle S, Poulalhon N, Debarbieux S, et al. Tracking of second primary melanomas under BRAF blockers. JAMA dermatol 2013 (in press).
5. Calzavara-Pinton P, Longo C, Venturini M, et al. Reflectance confocal microscopy for in vivo skin imaging. Photochem Photobiol 2008; 84: 1421-30.
6. Gareau DS, Patel YG, Rajadhyaksha M,. Basic principles of reflectance confocal microscopy. in: Reflectance Confocal Microscopy of Cutaneous Tumors (, Gonzàlez S, Gill M, Halpern AC, eds), 1st edn. London: Informa Healthcare, 2008; 1-6.
7. Guitera P, Pellacani G, Crotty KA, et al. The impact of in vivo reflectance confocal microscopy on the diagnostic accuracy of lentigo maligna and equivocal pigmented and nonpigmented macules of the face. J Invest Dermatol 2010; 130: 2080-91.
8. Pellacani G, Cesinaro AM, Seidenari S,. Reflectance-mode confocal microscopy of pigmented skin lesions-improvement in melanoma diagnostic specificity. J Am Acad Dermatol 2005; 53: 979-85.
9. Pellacani G, Longo C, Malvehy J, et al. In vivo confocal microscopic and histopathologic correlations of dermoscopic features in 202 melanocytic lesions. Arch Dermatol 2008; 144: 1597-608.
10. Pellacani G, Vinceti M, Bassoli S, et al. Reflectance confocal microscopy and features of melanocytic lesions: an internet-based study of the reproducibility of terminology. Arch Dermatol 2009; 145: 1137-43.
11. Segura S, Puig S, Carrera C, et al. Development of a two-step method for the diagnosis of melanoma by reflectance confocal microscopy. J Am Acad Dermatol 2009; 61: 216-29.
12. Carrera C, Palou J, Malvehy J, et al. Early stages of melanoma on the limbs of high-risk patients: clinical, dermoscopic, reflectance confocal microscopy and histopathological characterization for improved recognition. Acta Derm Venereol 2011; 91: 137-46.
13. Nobre Moura F, Dalle S, Depaepe L, et al. Melanoma: early diagnosis using in vivo reflectance confocal microscopy. Clin Exp Dermatol 2011; 36: 209-11.
14. Pellacani G, Farnetani F, Gonzalez S, et al. In vivo confocal microscopy for detection and grading of dysplastic nevi: a pilot study. J Am Acad Dermatol 2012; 66: e109-21.
15. Menzies SW, Gutenev A, Avramidis M, et al. Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol 2001; 137: 1583-9.
16. Debarbieux S, Depaepe L, Poulalhon N, et al. Reflectance confocal microscopy accurately discriminates between benign and malignant melanocytic lesions exhibiting a 'dermoscopic island'. J Eur Acad Dermatol Venereol 2013; 27: e159-65.